bpc-157 biolab — 10mg – Thistle BioLabs BPC-157 10mg TB-500 10mg Blend

Mechanism of Action Angiogenic Modulation and Growth Factor Upregulation The mechanism of BPC-157 is centered on its ability to trigger the Early Growth Response 1 (EGR-1) gene and subsequently upregulate the Vascular Endothelial Growth Factor (VEGF)

Many customers tell us they love how easy it is to stay consistent with BPC-157 supplementation, even with busy schedules

Here is why that matters

The safety profile of DSIP rests largely on older animal studies and a limited number of small human studies

Nano arthroscopy in the office has revolutionized treatment and provides immediate benefit under local anaesthetic and most patients get back to sports within two weeks

Mean Elimination Half-Life (t): In rats, the average elimination half-life after a single intravenous (IV) administration is 15.2 minutes